Advertisement
Screener

Arbutus Biopharma Corp (ABUS) Graph

ABUS Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $1.01M; Research and development $2.90M; Operating expenses $6.98M; Income tax (m).
  • 2026-03-31: Revenue $179.13M; Research and development $4.12M; Operating expenses $10.22M; Income tax $0.00.
  • 2025-12-31: Revenue $1.05M*; Research and development $5.01M*; Operating expenses $6.34M*; Income tax (m).
  • 2025-09-30: Revenue $529.00K; Research and development $5.78M; Operating expenses $9.19M; Income tax (m).

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ABUS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.CollaborationAnd Contracts$202.00KNon Cash Royalty$180.00KLicense$632.00KRevenue$1.01MOperating expenses$6.98MOperating income-$5.96MResearch & development$2.90MNet income-$5.14M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ABUS revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$1.01MRevenue$1.01MOperating expenses$6.98MOperating income-$5.96MResearch & development$2.90MNet income-$5.14M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$1.01M$2.90M$6.98M(m)-$5.14M
2026-03-31$179.13M$4.12M$10.22M$0.00$169.69M
2025-12-31$1.05M*$5.01M*$6.34M*(m)-$3.76M*
2025-09-30$529.00K$5.78M$9.19M(m)-$7.74M
2025-06-30$10.74M$5.50M$9.25M(m)$2.52M
2025-03-31$1.76M$8.96M$27.46M(m)-$24.53M
2024-09-30$1.34M$14.27M$22.78M(m)-$19.72M
2024-06-30$1.73M$15.55M$23.31M(m)-$19.80M
2024-03-31$1.53M$15.40M$20.89M(m)-$17.88M
2023-09-30$4.66M$20.17M$26.22M$0.00-$20.10M
2023-06-30$4.65M$17.69M$23.04M$0.00-$17.09M
2023-03-31$6.69M$18.27M$24.10M$0.00-$16.34M
2022-09-30$5.95M$20.05M$23.76M$0.00-$17.57M
2022-06-30$14.24M$22.94M$28.35M$0.00-$14.19M
2022-03-31$12.58M$18.46M$23.55M$4.44M-$15.77M
2021-09-30$3.34M$16.71M$21.75M$0.00-$19.16M
2021-06-30$2.33M$15.80M$20.97M$0.00-$19.39M
2021-03-31$2.11M$13.78M$17.79M$0.00-$16.38M
2020-09-30$1.52M$12.06M$16.74M$0.00-$18.75M
2020-06-30$1.51M$10.46M$14.65M$0.00-$14.09M
2020-03-31$1.49M$10.42M$14.64M$0.00-$13.86M
2019-12-31$1.62M(m)(m)(m)-$24.65M
2019-09-30$3.06M$17.73M$94.09M-$12.66M-$82.50M
2019-06-30$653.00K$12.74M$21.30M$0.00-$23.32M
2019-03-31$679.00K$14.71M$19.88M$0.00-$23.25M
2018-12-31$1.68M(m)(m)(m)-$18.25M
2018-09-30$1.59M$16.57M$34.01M-$4.28M-$24.47M
2018-06-30$1.24M$16.36M$23.29M(m)$3.09M
2018-03-31$1.44M$13.95M$19.84M(m)-$17.43M
2017-12-31$2.53M(m)(m)(m)-$35.93M
2017-09-30$6.89M$15.54M$19.79M$0.00-$11.60M
2017-06-30$1.04M$15.45M$20.52M$0.00-$18.25M
2017-03-31$235.00K$13.87M$18.53M(m)-$18.63M
2016-12-31-$195.00K(m)(m)(m)-$218.69M
2016-09-30$774.00K$15.74M$19.75M$0.00-$19.59M
2016-06-30$309.00K$15.21M$195.56M-$64.86M-$130.00M
2016-03-31$603.00K$13.14M$20.58M(m)-$15.87M
2015-12-31$12.69M(m)(m)(m)-$5.26M
2015-09-30$4.07M$16.35M$62.20M-$15.20M-$28.98M
2015-06-30$3.44M$9.69M$17.86M$0.00-$14.89M
2015-03-31$4.68M$10.56M$22.69M(m)-$11.99M
2014-12-31$4.35M(m)(m)(m)-$6.17M
2014-09-30$4.36M$9.31M$11.21M$0.00-$8.60M
2014-06-30$1.81M$9.30M$11.23M(m)-$6.08M
2014-03-31$4.43M$8.20M$10.39M(m)-$17.98M
2013-12-31$752.00K(m)(m)(m)-$2.60M
2013-09-30$2.96M$5.51M$6.61M(m)-$5.91M
2013-06-30$2.84M$4.91M$5.92M(m)-$3.02M
2013-03-31$2.13M$4.07M$5.13M(m)-$2.55M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$180.14M$7.02M$17.20M$0.00$164.55M
2025-06-30$12.50M$14.46M$36.71M(m)-$22.00M
2024-06-30$3.26M$30.95M$44.20M(m)-$37.67M
2023-06-30$11.34M$35.97M$47.14M$0.00-$33.43M
2022-06-30$26.82M$41.40M$51.91M$4.44M-$29.96M
2021-06-30$4.44M$29.58M$38.76M$0.00-$35.77M
2020-06-30$3.00M$20.88M$29.29M$0.00-$27.95M
2019-06-30$1.33M$27.45M$41.17M$0.00-$46.57M
2018-06-30$2.68M$30.30M$43.13M(m)-$14.34M
2017-06-30$1.27M$29.32M$39.06M$0.00-$36.88M
2016-06-30$912.00K$28.36M$216.14M-$64.86M-$145.87M
2015-09-30$4.07M(m)(m)(m)(m)
2015-06-30$8.12M$20.25M$40.55M$0.00-$26.88M
2014-09-30$4.36M(m)(m)(m)(m)
2014-06-30$6.24M$17.50M$21.62M(m)-$24.07M
2013-06-30$4.97M$8.98M$11.04M(m)-$5.56M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$13.03M$20.23M$45.90M(m)-$29.75M
2024-09-30$4.60M$45.23M$66.98M(m)-$57.39M
2023-09-30$16.00M$56.14M$73.35M$0.00-$53.54M
2022-09-30$32.77M$61.46M$75.67M$4.44M-$47.52M
2021-09-30$7.78M$46.29M$60.51M$0.00-$54.93M
2020-09-30$4.53M$32.95M$46.03M$0.00-$46.70M
2019-09-30$4.39M$45.18M$135.26M-$12.66M-$129.07M
2018-09-30$1.59M$46.87M$77.14M-$4.28M-$24.47M
2017-09-30$8.17M$44.85M$58.85M$0.00-$48.48M
2016-09-30$1.69M$44.10M$235.89M-$64.86M-$165.47M
2015-09-30$12.19M$36.60M$102.75M-$15.20M-$55.86M
2014-09-30$10.60M$26.81M$32.83M$0.00-$32.67M
2013-09-30$7.94M$14.49M$17.65M(m)-$11.46M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$14.08M$25.24M$52.24M$0.00-$33.50M
2024-12-31$6.17M$54.04M$82.49M$0.00-$69.92M
2023-12-31$18.14M$73.70M$96.24M$0.00-$72.85M
2022-12-31$39.02M$84.41M$104.47M$4.44M-$69.46M
2021-12-31$10.99M$65.50M$84.51M$0.00-$76.25M
2020-12-31$6.91M$49.34M$64.72M$0.00-$63.74M
2019-12-31$6.01M$57.60M$149.91M-$12.66M-$153.72M
2018-12-31$5.95M$57.93M$95.72M-$4.28M-$57.06M
2017-12-31$10.70M$62.68M$121.63M-$24.32M-$84.41M
2016-12-31$1.49M$61.25M$493.13M-$105.00M-$384.16M
2015-12-31$23.28M$51.51M$127.19M-$16.18M-$62.72M
2014-12-31$14.95M$38.71M$48.39M$0.00-$38.84M
2013-12-31$15.46M$21.46M$27.62M$0.00-$14.06M
2012-12-31$14.11M$18.04M$27.05M(m)$29.61M
2011-12-31$16.81M$20.13M$27.51M(m)-$10.08M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Apnimed, Inc. (APMD)United States$0.899B
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Savara Inc (SVRA)United States$1.044B-9.10
Theravance Biopharma, Inc. (TBPH)$0.885B16.40